The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following: 1. Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance. 2. Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance. 3. The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
170
Every patient will be evaluated by an in person dermatologist present at the screening.
Every patient will be evaluated online via a store and forward teledermatology modality.
University of California, Davis Shifa Community Clinic
Sacramento, California, United States
Aggregated diagnostic concordance
Aggregated diagnostic concordance which is defined as the agreement of the in-person dermatologist's principle diagnosis with the teledermatologist's primary diagnosis or any of the differential diagnoses.
Time frame: At the time of dermatologist evaluation (Day 1)
Primary diagnostic concordance
Diagnostic concordance between the in-person dermatologist and the teledermatologist for their primary diagnosis.
Time frame: At the time of dermatologist evaluation (Day 1)
Categorical diagnostic concordance
Diagnostic concordance between the in-person dermatologist and teledermatologist based on standard clinical diagnostic categories for each lesion.
Time frame: At the time of dermatologist evaluation (Day 1)
Management concordance
The concordance between the in-person dermatologist and teledermatologist for the chosen management plan for each lesion.
Time frame: At the time of dermatologist evaluation (Day 1)
Sensitivity
The sensitivity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant.
Time frame: At the time of dermatologist evaluation (Day 1)
Specificity
The specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant.
Time frame: At the time of dermatologist evaluation (Day 1)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.